Molecular Determinants of Thyroid Cancer Progression: Thyroid Hormone Signaling, the BRAF/MAPK Pathway, and Emerging miRNA Biomarkers. [PDF]
Lasa M, Contreras-Jurado C.
europepmc +1 more source
Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik +3 more
wiley +1 more source
Optimization of an <i>ex vivo</i> model to test the ability of chemicals to disrupt thyroid hormone synthesis. [PDF]
Melchiors M +7 more
europepmc +1 more source
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz +2 more
wiley +1 more source
Predictive value of thyroid hormone levels for postpartum hemorrhage in hypothyroidism-complicated pregnancy. [PDF]
Zhu Y, Liu L, Wang C, Chen X, Huang C.
europepmc +1 more source
ABSTRACT Introduction/Aim Optimizing Management of Endocrine Complications in Duchenne Muscular Dystrophy (OPTIMIZE DMD) is an international consortium of clinicians created to advance endocrine and bone clinical care in DMD. The aim of this study was to better understand current views and practices regarding investigation and management of growth and ...
Claire L. Wood +131 more
wiley +1 more source
Apalutamide-Induced Hypothyroidism Associated With Increased Thyroid Hormone Clearance in Metastatic Prostate Cancer Patient: A Case Report. [PDF]
Furumido J, Yamashita A, Kato R, Hori K.
europepmc +1 more source
Machine Learning Prediction of Transthyretin Binding for Thyroid Hormone Transport Disruption for Chemical Risk Assessment. [PDF]
Hou S, Ji C, Reh CM, Ruiz P.
europepmc +1 more source

